-
Characteristics of the included randomized controlled trials.
Characteristics of the included randomized controlled trials. -
Treatment duration (days) in Stage 2 for the entire cohort and by treatment arm.
Treatment duration (days) in Stage 2 for the entire cohort and by treatment arm. -
Comparative efficacy between ALF-5755 and placebo on the PR slope from H0 to ...
Comparative efficacy between ALF-5755 and placebo on the PR slope from H0 to H72 and the survival without liver transplantation. -
An adaptable implementation package targeting evidence-based indicators in pr...
BackgroundIn primary care, multiple priorities and system pressures make closing the gap between evidence and practice challenging. Most implementation studies focus on single... -
Effects of a depression-focused internet intervention in slot machine gambler...
BackgroundProblematic and pathological gambling have been linked to depression. Despite a high demand for treatment and negative financial consequences, only a small fraction of... -
General practice characteristics at baseline by trial arm.
General practice characteristics at baseline by trial arm. -
r37980778c78--a8e219bf88c2988ea0272059dab08a58
Main characteristics of the studied patients at time of inclusion. -
Values of PR slope from H0 to H72 according to the etiology of the acute live...
Values of PR slope from H0 to H72 according to the etiology of the acute liver failure. -
ALF-5755 efficacy in HBV or AIH related severe acute hepatitis.
ALF-5755 efficacy in HBV or AIH related severe acute hepatitis. -
r37980778c78--db157ef7b9b5af0330a71036c30b240c
BackgroundExcellent adherence to tuberculosis (TB) treatment is critical to cure TB and avoid the emergence of resistance. Wirelessly observed therapy (WOT) is a novel patient... -
r37980778c78--90c90658fb585a94bf66fa236da297e7
BackgroundUNAIDS recently defined the 90-90-90 target as a way to end the HIV epidemic. However, the proportion of virological success following antiretroviral therapy (ART) may... -
Virological success (<400 copies/ml) at 12 months–on-treatment analysis.
Virological success (<400 copies/ml) at 12 months–on-treatment analysis. -
r37980778c78--fa97b264d9a1a16e4ba2c6671c567d44
BackgroundWe developed and tested the effectiveness of a tailored health information technology driven intervention: “Talking Prescriptions” (Talking Rx) to improve medication... -
Efficacy of Probiotic Supplementation Therapy for <i>Helicobacter pylori</i> ...
BackgroundTraditional Helicobacter pylori (H. pylori) eradication therapies have shown efficacies below 80% in several studies, and their use has been accompanied by... -
Cost-effectiveness analysis: Mean probability sensitivity analysis outcomes a...
Cost-effectiveness analysis: Mean probability sensitivity analysis outcomes at the practice level for the primary risky prescribing and BP control outcomes. -
Two-way table of predicted means (standard errors) and differences of means (...
Two-way table of predicted means (standard errors) and differences of means (p-values) for the co-primary endpoints of weight, waist circumference, and fasting blood glucose by... -
Two-way table of predicted means (standard errors) and differences of means (...
Two-way table of predicted means (standard errors) and differences of means (p-values) for the secondary endpoints of blood pressure, blood lipids, and depressive symptoms by... -
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of AL...
ObjectiveNo efficient medical treatment is available for severe acute hepatitis (SAH) except N-acetylcysteine for acetaminophen-induced acute liver failure. The human C-type... -
Subgroup analysis results regarding eradication side effects.
Subgroup analysis results regarding eradication side effects.
